Effectiveness of Infliximab Biosimilar in Crohn’s Disease: A Dime, A Dozen

Posted on April 26, 2019 by Gastroenterology Journal

Meyer A, Rudant J, Drouin J, et al. Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study. Ann Intern Med 2019;170:99–107.

This entry was posted in News. Bookmark the permalink.